KLF4 and cancer: Meanwhile, PC-9/GR/sh-BTK cells exhibited significantly lower levels of cancer stemness markers such as KLF4, SOX2, NANOG, and CD133, than its counterparts, whereas the pBTK-N1 cells expressed the highest levels of these markers (Fig. 4E, F).